James E. Flynn 13D and 13G filings for IVERIC bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 09:45 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | James E. Flynn | 3,424,852 2.520% | -3,176,148 (-48.12%) | Filing |
| 2022-10-04 4:32 pm Purchase | 2022-10-03 | 13G | IVERIC bio, Inc. ISEE | James E. Flynn | 6,601,000 5.590% | 1,839,862 (+38.64%) | Filing |
| 2022-02-11 4:10 pm Sale | 2021-12-31 | 13G | IVERIC bio, Inc. ISEE | James E. Flynn | 4,761,138 4.150% | -1,006,271 (-17.45%) | Filing |
| 2021-02-12 12:28 pm Unchanged | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | James E. Flynn | 5,767,409 6.440% | 0 (Unchanged) | Filing |
| 2020-07-01 1:52 pm Purchase | 2020-06-22 | 13G | IVERIC bio, Inc. ISEE | James E. Flynn | 5,767,409 6.820% | 5,767,409 (New Position) | Filing |